FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 /PRNewswire/ -- Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and ...
Cerus Endovascular Ltd has received CE Mark approval for the commercial sale of its Contour Neurovascular System for the treatment of intra-cranial aneurysms (IAs) across the European Union (EU). The ...
Cerus Endovascular Ltd. today announced that it has received CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across the ...
FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Aug. 4, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica ...
Cerus Endovascular has announced that it has received European CE Mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The device is a ...
The U.S. FDA has granted breakthrough device designation to Cerus Endovascular Ltd. for its Contour neurovascular system for the treatment of intracranial aneurysms. The company is targeting the ...